These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19596193)

  • 1. Design, synthesis and evaluation of a novel cyclohexanamine class of neuropeptide Y Y1 receptor antagonists.
    Cho K; Ando M; Kobayashi K; Miyazoe H; Tsujino T; Ito S; Suzuki T; Tanaka T; Tokita S; Sato N
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4781-5. PubMed ID: 19596193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of a series of 2,4-diaminopyridines as neuropeptide Y Y1 receptor antagonists with reduced hERG activity.
    Kameda M; Kobayashi K; Ito H; Miyazoe H; Tsujino T; Nakama C; Kawamoto H; Ando M; Ito S; Suzuki T; Kanno T; Tanaka T; Tahara Y; Tani T; Tanaka S; Tokita S; Sato N
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4325-9. PubMed ID: 19487123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of substituted 4-alkoxy-2-aminopyridines as novel neuropeptide Y1 receptor antagonists.
    Sato N; Shibata T; Jitsuoka M; Ohno T; Takahashi T; Hirohashi T; Kanno T; Iwaasa H; Kanatani A; Fukami T
    Bioorg Med Chem Lett; 2004 Apr; 14(7):1761-4. PubMed ID: 15026066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,3-Disubstituted benzazepines as novel, potent, selective neuropeptide Y Y1 receptor antagonists.
    Murakami Y; Hara H; Okada T; Hashizume H; Kii M; Ishihara Y; Ishikawa M; Shimamura M; Mihara S; Kato G; Hanasaki K; Hagishita S; Fujimoto M
    J Med Chem; 1999 Jul; 42(14):2621-32. PubMed ID: 10411482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and biological evaluation of substituted 2-cyclohexyl-4-phenyl-1H-imidazoles: potent and selective neuropeptide Y Y5-receptor antagonists.
    Blum CA; Zheng X; De Lombaert S
    J Med Chem; 2004 Apr; 47(9):2318-25. PubMed ID: 15084130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of a series of novel 2-[(4-chlorophenoxy)methyl]benzimidazoles as selective neuropeptide Y Y1 receptor antagonists.
    Zarrinmayeh H; Nunes AM; Ornstein PL; Zimmerman DM; Arnold MB; Schober DA; Gackenheimer SL; Bruns RF; Hipskind PA; Britton TC; Cantrell BE; Gehlert DR
    J Med Chem; 1998 Jul; 41(15):2709-19. PubMed ID: 9667962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel potent neuropeptide Y Y5 receptor antagonists: synthesis and structure-activity relationships of phenylpiperazine derivatives.
    Takahashi T; Sakuraba A; Hirohashi T; Shibata T; Hirose M; Haga Y; Nonoshita K; Kanno T; Ito J; Iwaasa H; Kanatani A; Fukami T; Sato N
    Bioorg Med Chem; 2006 Nov; 14(22):7501-11. PubMed ID: 16919461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of novel tricyclic benzo[4.5]cyclohepta[1.2]pyridine derivatives as NMDA/NR2B antagonists.
    McIntyre CJ; McCauley JA; Bednar B; Bednar RA; Butcher JW; Claremon DA; Cunningham ME; Freidinger RM; Gaul SL; Homnick CF; Koblan KS; Mosser SD; Romano JJ; Liverton NJ
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5132-5. PubMed ID: 19648007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of substituted 2,4,4-triarylimidazoline derivatives as potent and selective neuropeptide Y Y5 receptor antagonists.
    Sato N; Jitsuoka M; Ishikawa S; Nagai K; Tsuge H; Ando M; Okamoto O; Iwaasa H; Gomori A; Ishihara A; Kanatani A; Fukami T
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1670-4. PubMed ID: 19233647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of new arylsulfonamidomethylcyclohexyl derivatives as human neuropeptide Y Y5 receptor antagonists for the treatment of obesity.
    Moreno A; Pérez S; Galiano S; Juanenea L; Erviti O; Frígola C; Aldana I; Monge A
    Eur J Med Chem; 2004 Jan; 39(1):49-58. PubMed ID: 14987833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of a series of 2,4-diaminopyridine derivatives as potential positron emission tomography tracers for neuropeptide Y Y1 receptors.
    Kameda M; Ando M; Nakama C; Kobayashi K; Kawamoto H; Ito S; Suzuki T; Tani T; Ozaki S; Tokita S; Sato N
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5124-7. PubMed ID: 19640706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of new hydrazide derivatives as neuropeptide Y Y5 receptor antagonists for the treatment of obesity.
    Juanenea L; Galiano S; Erviti O; Moreno A; Pérez S; Aldana I; Monge A
    Bioorg Med Chem; 2004 Sep; 12(17):4717-23. PubMed ID: 15358298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of tetrasubstituted imidazolines as potent and selective neuropeptide Y Y5 receptor antagonists: reduced human ether-a-go-go related gene potassium channel binding affinity and potent antiobesity effect.
    Sato N; Ando M; Ishikawa S; Jitsuoka M; Nagai K; Takahashi H; Sakuraba A; Tsuge H; Kitazawa H; Iwaasa H; Mashiko S; Gomori A; Moriya R; Fujino N; Ohe T; Ishihara A; Kanatani A; Fukami T
    J Med Chem; 2009 May; 52(10):3385-96. PubMed ID: 19459652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology and quantitative structure-activity relationships of imidazolylpropylguanidines with mepyramine-like substructures as non-peptide neuropeptide Y Y1 receptor antagonists.
    Dove S; Michel MC; Knieps S; Buschauer A
    Can J Physiol Pharmacol; 2000 Feb; 78(2):108-15. PubMed ID: 10737673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel and potent NPY5 receptor antagonists derived from virtual screening and iterative parallel chemistry design.
    Guba W; Neidhart W; Nettekoven M
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1599-603. PubMed ID: 15745805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A preliminary study of the metabolic stability of a series of benzoxazinone derivatives as potent neuropeptide Y5 antagonists.
    Dordal A; Lipkin M; Macritchie J; Mas J; Port A; Rose S; Salgado L; Savic V; Schmidt W; Serafini MT; Spearing W; Torrens A; Yeste S
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3679-84. PubMed ID: 15982873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The identification and optimisation of novel and selective diamide neuropeptide Y Y2 receptor antagonists.
    Lunniss GE; Barnes AA; Barton N; Biagetti M; Bianchi F; Blowers SM; Caberlotto L; Emmons A; Holmes IP; Montanari D; Norris R; Walters DJ; Watson SP
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4022-5. PubMed ID: 19581086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, syntheses, and structure-activity relationships of novel NPY Y5 receptor antagonists: 2-{3-Oxospiro[isobenzofuran-1(3H),4'-piperidin]-1'-yl}benzimidazole derivatives.
    Ogino Y; Ohtake N; Nagae Y; Matsuda K; Moriya M; Suga T; Ishikawa M; Kanesaka M; Mitobe Y; Ito J; Kanno T; Ishihara A; Iwaasa H; Ohe T; Kanatani A; Fukami T
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5010-4. PubMed ID: 18723347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of 5,5-diphenylimidazolones as potent human neuropeptide Y5 receptor antagonists.
    Gillman KW; Higgins MA; Poindexter GS; Browning M; Clarke WJ; Flowers S; Grace JE; Hogan JB; McGovern RT; Iben LG; Mattson GK; Ortiz A; Rassnick S; Russell JW; Antal-Zimanyi I
    Bioorg Med Chem; 2006 Aug; 14(16):5517-26. PubMed ID: 16697206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure-activity relationship of N-(3-azabicyclo[3.1.0]hex-6-ylmethyl)-5-(2-pyridinyl)-1,3-thiazol-2-amines derivatives as NPY Y5 antagonists.
    Biagetti M; Leslie CP; Mazzali A; Seri C; Pizzi DA; Bentley J; Genski T; Di Fabio R; Zonzini L; Caberlotto L
    Bioorg Med Chem Lett; 2010 Aug; 20(16):4741-4. PubMed ID: 20630754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.